$DFTX Definium Therapeutics (NASDAQFTX) Stock Price Expected to Rise, HC Wainwright Analyst Says Definium Therapeutics (NASDAQFTX - Get Free Report) had its price objective hoisted by investment analysts at HC Wainwright from $55.00 to $70.00 in a research note issued on Monday,Benzinga reports. The firm presently has a "buy" rating on the stock. HC Wainwright's target price points to a potential upside of 301.15% from the company's current price. https://www.marketbeat.com/instant-...o-rise-hc-wainwright-analyst-says-2026-03-02/
